Literature DB >> 21702397

Spice: a legal marijuana equivalent.

Lucas A Johnson1, Rebecca L Johnson, Chris Alfonzo.   

Abstract

Spice, an herbal mixture containing synthetic cannabinoids, is a legal drug increasingly abused by adolescents and young adults for its narcotic-like effects. A paucity of English language literature exists on the clinical effects of Spice use. A case report of substance-induced psychosis and a summary of available literature follows later.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21702397     DOI： 10.7205/milmed-d-10-00356

Source DB:  PubMed          Journal:  Mil Med        ISSN： 0026-4075            Impact factor:   1.437


  13 in total

Review 1.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

2.  Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.

Authors:  Patrick D Skosnik; Giri P Krishnan; Deepak C D'Souza; William P Hetrick; Brian F O'Donnell
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

Review 3.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 4.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

5.  Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.

Authors:  Jose Cortes-Briones; Patrick D Skosnik; Daniel Mathalon; John Cahill; Brian Pittman; Ashley Williams; R Andrew Sewell; Mohini Ranganathan; Brian Roach; Judith Ford; Deepak Cyril D'Souza
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

6.  AKI associated with synthetic cannabinoids: a case series.

Authors:  Gautam Kantilal Bhanushali; Gaurav Jain; Huma Fatima; Leah J Leisch; Denyse Thornley-Brown
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 8.237

Review 7.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

Review 8.  Marijuana: current concepts(†).

Authors:  Donald E Greydanus; Elizabeth K Hawver; Megan M Greydanus; Joav Merrick
Journal:  Front Public Health       Date:  2013-10-10

Review 9.  Gone to Pot - A Review of the Association between Cannabis and Psychosis.

Authors:  Rajiv Radhakrishnan; Samuel T Wilkinson; Deepak Cyril D'Souza
Journal:  Front Psychiatry       Date:  2014-05-22       Impact factor: 4.157

10.  Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats.

Authors:  Devan M Gomez; Thomas J Everett; Lindsey R Hamilton; Ajit Ranganath; Joseph F Cheer; Erik B Oleson
Journal:  Neuropharmacology       Date:  2020-10-25       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.